A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)
Public ClinicalTrials.gov record NCT05841030. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study of Disease Characteristics and Real-life Standard of Care Effectiveness in Patients With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including an SSRI or SNRI
Study identification
- NCT ID
- NCT05841030
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Janssen Research & Development, LLC
- Industry
- Enrollment
- 545 participants
Conditions and interventions
Conditions
Interventions
- No Intervention Other
Other
Eligibility (public fields only)
- Age range
- 18 Years to 74 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 27, 2023
- Primary completion
- Feb 26, 2026
- Completion
- Feb 26, 2026
- Last update posted
- Apr 22, 2026
2023 – 2026
United States locations
- U.S. sites
- 18
- U.S. states
- 11
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 | — |
| University of Alabama at Birmingham 1 | Homewood | Alabama | 35209 | — |
| ATP Clinical Research | California City | California | 92626 | — |
| University of Connecticut Health Center | Farmington | Connecticut | 06030 | — |
| Flagler Hospital and Florida Center for TMS | Saint Augustine | Florida | 32086 | — |
| Center for Revitalizing Psychiatry | Sarasota | Florida | 34237 | — |
| Interventional Psychiatry of Tampa Bay | Tampa | Florida | 33629 | — |
| Atlanta Behavioral Research, LLC | Atlanta | Georgia | 30338 | — |
| Psych Atlanta, P.C. | Marietta | Georgia | 30060 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| Loyola University Medical Center | Maywood | Illinois | 60153 | — |
| Baber Research Group | Naperville | Illinois | 60563 | — |
| Lumin Health | Newton | Massachusetts | 02459 | — |
| Univeristy of Massachusetts | Worcester | Massachusetts | 01605-2610 | — |
| Missouri University Health Care South Providence Psychiatry | Columbia | Missouri | 65201 | — |
| Signature Research Associates Inc. | Fairlawn | Ohio | 44333 | — |
| Lehigh Center for Clinical Research | Allentown | Pennsylvania | 18104 | — |
| Seattle Neuropsychiatric Treatment Center | Tacoma | Washington | 98405-1954 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 77 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05841030, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 22, 2026 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05841030 live on ClinicalTrials.gov.